Recent advances in the management of juvenile systemic sclerosis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Review of Clinical Immunology

• Publication date

  2017-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/1744666X.2017.1243467PMID 27690679
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multimodality thoracic imaging of juvenile systemic sclerosis: emphasis on clinical correlation and high-resolution CT of pulmonary fibrosis.

  2015cited by this paper
• OP0307 Infrared Thermography After Cold Challenge: Validation in Diagnosis of Raynaud's Phenomenon in Pediatric Age

  2015cited by this paper
• A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.

  2015cited by this paper
• Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study

  2015cited by this paper
• Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.

  2015cited by this paper
• Gastrointestinal Manifestations, Malnutrition, and Role of Enteral and Parenteral Nutrition in Patients With Scleroderma

  2015cited by this paper
• Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

  2014cited by this paper
• Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis.

  2014cited by this paper
• Early Systemic Sclerosis: Analysis of the Disease Course in Patients With Marker Autoantibody and/or Capillaroscopic Positivity

  2014cited by this paper
• Nailfold capillaroscopy in juvenile rheumatic diseases: known measures, patterns and indications.

  2014cited by this paper
• Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

  2014cited by this paper
• Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study.

  2014cited by this paper
• Scleroderma Renal Crisis

  2014cited by this paper
• Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.

  2014cited by this paper
• Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.

  2014cited by this paper
• Lung transplantation in patients with scleroderma

  2013cited by this paper
• Scleroderma in children: an update

  2013cited by this paper
• Two-year Results of an Open Pilot Study of a 2-treatment Course with Rituximab in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement

  2013cited by this paper
• An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

  2013cited by this paper
• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  2013cited by this paper
• Gastrointestinal motility disorder assessment in systemic sclerosis.

  2013cited by this paper
• A preliminary disease severity score for juvenile systemic sclerosis.

  2012cited by this paper
• Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis

  2011cited by this paper
• Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.

  2011cited by this paper
• Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

  2010cited by this paper
• Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone

  2010cited by this paper
• Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland

  2010cited by this paper
• Characteristics of Patients with Juvenile Onset Systemic Sclerosis in an Adult Single-center Cohort

  2010cited by this paper
• Factors affecting survival in juvenile systemic sclerosis.

  2009cited by this paper
• Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.

  2009cited by this paper
• B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.

  2009cited by this paper
• Evaluation of Heart Rhythm Variability and Arrhythmia in Children with Systemic and Localized Scleroderma

  2008cited by this paper
• Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

  2008cited by this paper
• Cardiac Magnetic Resonance Imaging with Pharmacological Stress Perfusion and Delayed Enhancement in Asymptomatic Patients with Systemic Sclerosis

  2008cited by this paper
• Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.

  2008cited by this paper
• Systemic sclerosis and localized scleroderma in childhood.

  2008cited by this paper
• Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

  2008cited by this paper
• B cell infiltration in systemic sclerosis-associated interstitial lung disease.

  2007cited by this paper
• Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients.

  2007cited by this paper
• The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.

  2007cited by this paper
• Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and Tissue-Doppler echography study.

  2006cited by this paper
• Cyclophosphamide versus placebo in scleroderma lung disease.

  2006cited by this paper
• Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score.

  2006cited by this paper
• Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.

  2006cited by this paper
• A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

  2006cited by this paper
• Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.

  2006cited by this paper
• Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.

  2006cited by this paper
• Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis open label extension to a double-blind trial

  2006cited by this paper
• Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis

  2005cited by this paper
• Transforming growth factor β1 gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian population

  2003cited by this paper
• Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.

  2003cited by this paper
• Severe cardiac involvement in children with systemic sclerosis and myositis.

  2002cited by this paper
• A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.

  2001cited by this paper
• Lung transplantation in patients with scleroderma.

  2001cited by this paper
• Assessment of damage and activity in systemic sclerosis

  2000cited by this paper
• Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey.

  2000cited by this paper
• Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis.

  1999cited by this paper
• Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.

  1998cited by this paper
• Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument.

  1998cited by this paper
• The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.

  1997cited by this paper
• Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.

  1996cited by this paper
• Scleroderma renal crisis.

  1996cited by this paper
• Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.

  1983cited by this paper

• An updated overview of Juvenile systemic sclerosis in a French cohort

  2025cites this paper
• Assessing Lung Involvement in Paediatric Rheumatic Diseases: A Retrospective Evaluation of the Limitations of Spirometry

  2025cites this paper
• Lung involvement in children with newly diagnosed rheumatic diseases: characteristics and associations

  2022cites this paper
• A comprehensive review of immunosuppressive drugs in pediatric dermatoses: Part II – methotrexate and mycophenolate mofetil

  2022cites this paper
• Pulmonary involvement in patients with juvenile systemic sclerosis.

  2021influential citation
• Overview of Pediatric Rheumatology

  2021cites this paper
• Esclerodermia sistémica juvenil en una lactante: reporte de caso

  2020cites this paper
• Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study

  2020cites this paper
• The use of systemic medications in pediatric dermatoses: A review

  2019influential citation
• Edema of Hands and Hypopigmented Lesions on Her Neck and Cheeks

  2019cites this paper
• Kollagenosen im Kindes- und Jugendalter

  2018cites this paper
• Scleroderma in children.

  2017cites this paper
• New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction

  2017cites this paper